Literature DB >> 30013261

Sjögren's and plasma cell variant Castleman disease: a case report.

Yvonne A Dei-Adomakoh1, Leslie Quarcoopome2, Afua D Abrahams3, Catherine I Segbefia4, Dzifa I Dey5.   

Abstract

Castleman disease is a rare cause of lymphoid hyperplasia and may result in localized symptoms or an aggressive, multisystem disorder. It can mimic other diseases like lymphoma or tuberculosis. It classically presents as a mediastinal mass that involves the lymphatic tissue primarily but can also affect extra lymphatic sites including the lungs, larynx, parotid glands, pancreas, meninges, and muscles. In HIV and HHV8-negative patients with idiopathic multi-centric Castleman disease, pathogenesis may involve autoimmune mechanisms. We highlight and report a case of a 34-year-old Ghanaian female who was successfully diagnosed and managed for Sjögren's as well as plasma cell variant Castleman disease with combination chemotherapy and rituximab followed by eighteen months maintenance therapy with pulse chlorambucil and prednisolone and three monthly rituximab.

Entities:  

Keywords:  Plasma Cell Variant Castleman Disease; Rituximab; Sjögren's syndrome; chemotherapy; lymphadenopathy

Mesh:

Substances:

Year:  2018        PMID: 30013261      PMCID: PMC6026944          DOI: 10.4314/gmj.v52i1.9

Source DB:  PubMed          Journal:  Ghana Med J        ISSN: 0016-9560


  33 in total

1.  Systemic Castleman's disease in association with Evan's syndrome and vitiligo.

Authors:  J H Marsh; D S Colbourn; V Donovan; H Staszewski
Journal:  Med Pediatr Oncol       Date:  1990

2.  Multiple capillary hemangiomas: a distinctive lesion of multicentric Castleman's disease and POEMS syndrome.

Authors:  Rachita Misri; Vidya Kharkar; Ameet Dandale; Vidula Patel; Sunanda Mahajan; Uday Khopkar
Journal:  Indian J Dermatol Venereol Leprol       Date:  2008 Jul-Aug       Impact factor: 2.545

3.  Successful treatment of steroid-refractory autoimmune thrombocytopenia associated with Castleman disease with anti-CD-20 antibody (rituximab).

Authors:  Khalid Ibrahim; Irfan Maghfoor; Assem Elghazaly; Nasir Bakshi; Said Y Mohamed; Mahmoud Aljurf
Journal:  Hematol Oncol Stem Cell Ther       Date:  2011

4.  [Multicentric Castleman disease not associated with HHV-8 and HIV viruses].

Authors:  Denise de Fatima Forteski; Fernanda Calil Machado Netto; Andrea Barranjard Vannucci Lomonte; Bruno César Cavalcanti dos Anjos; Maria Claudia Nogueira Zerbini; Cristiano Augusto de Freitas Zerbini
Journal:  Rev Bras Reumatol       Date:  2014-08-26

5.  Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm.

Authors:  J Zulman; R Jaffe; N Talal
Journal:  N Engl J Med       Date:  1978-11-30       Impact factor: 91.245

Review 6.  Primary Sjogren syndrome: clinical and immunopathologic features.

Authors:  R I Fox; F V Howell; R C Bone; P Michelson
Journal:  Semin Arthritis Rheum       Date:  1984-11       Impact factor: 5.532

7.  Systemic connective tissue disease complicated by Castleman's disease: report of a case and review of the literature.

Authors:  Ginevra De Marchi; Salvatore De Vita; Martina Fabris; Cathryn Ann Scott; Gianfranco Ferraccioli
Journal:  Haematologica       Date:  2004-04       Impact factor: 9.941

8.  Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report.

Authors:  Magdalena Flejsierowicz; Mohamed S Ahmed; Petio Kotov; Yee Chung Cheng
Journal:  WMJ       Date:  2008-07

9.  Castleman disease of the thorax: radiologic features with clinical and histopathologic correlation.

Authors:  H P McAdams; M Rosado-de-Christenson; N F Fishback; P A Templeton
Journal:  Radiology       Date:  1998-10       Impact factor: 11.105

Review 10.  Emerging biological therapies in primary Sjogren's syndrome.

Authors:  M Ramos-Casals; P Brito-Zerón
Journal:  Rheumatology (Oxford)       Date:  2007-06-22       Impact factor: 7.580

View more
  3 in total

1.  Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases.

Authors:  Dao-Ping Sun; Wen-Ming Chen; Li Wang; Zhen Wang; Jin-Hua Liang; Hua-Yuan Zhu; Lei Fan; Yu-Jie Wu; Wei Xu; Jian-Yong Li
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-05       Impact factor: 4.553

2.  Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature.

Authors:  Yuejuan Pan; Zhuan Cui; Song Wang; Danxia Zheng; Zhenling Deng; Xinyu Tian; Hongxia Guo; Wenhan Bao; Sijia Zhou; Yue Wang
Journal:  BMC Nephrol       Date:  2020-12-04       Impact factor: 2.388

3.  Multicentric Castleman disease with TAFRO syndrome and Sjögren's.

Authors:  Zi Ying Li; Shirley Kim; SiYi Huang; Raza Mian
Journal:  Clin Case Rep       Date:  2019-10-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.